Alvaro L Garcia-Garcia1, Adrian Newman-Tancredi, E David Leonardo. 1. Department of Psychiatry, Division of Integrative Neuroscience, Columbia University and the New York State Psychiatric Institute, 1051 Riverside Dr. Box 87, New York, NY, 10032, USA, ag3149@columbia.edu.
Abstract
RATIONALE: Serotonin (5-HT) neurotransmission is intimately linked to anxiety and depression and a diverse body of evidence supports the involvement of the main inhibitory serotonergic receptor, the serotonin-1A (5-HT(1A)) subtype, in both disorders. OBJECTIVES: In this review, we examine the function of 5-HT(1A) receptor subpopulations and re-interpret our understanding of their role in mental illness in light of new data, separating both spatial (autoreceptor versus heteroreceptor) and the temporal (developmental versus adult) roles of the endogenous 5-HT(1A) receptors, emphasizing their distinct actions in mediating anxiety and depression-like behaviors. RESULTS: It is difficult to unambiguously distinguish the effects of different populations of the 5-HT(1A) receptors with traditional genetic animal models and pharmacological approaches. However, with the advent of novel genetic systems and subpopulation-selective pharmacological agents, direct evidence for the distinct roles of these populations in governing emotion-related behavior is emerging. CONCLUSIONS: There is strong and growing evidence for a functional dissociation between auto- and heteroreceptor populations in mediating anxiety and depressive-like behaviors, respectively. Furthermore, while it is well established that 5-HT(1A) receptors act developmentally to establish normal anxiety-like behaviors, the developmental role of 5-HT(1A) heteroreceptors is less clear, and the specific mechanisms underlying the developmental role of each subpopulation are likely to be key elements determining mood control in adult subjects.
RATIONALE: Serotonin (5-HT) neurotransmission is intimately linked to anxiety and depression and a diverse body of evidence supports the involvement of the main inhibitory serotonergic receptor, the serotonin-1A (5-HT(1A)) subtype, in both disorders. OBJECTIVES: In this review, we examine the function of 5-HT(1A) receptor subpopulations and re-interpret our understanding of their role in mental illness in light of new data, separating both spatial (autoreceptor versus heteroreceptor) and the temporal (developmental versus adult) roles of the endogenous 5-HT(1A) receptors, emphasizing their distinct actions in mediating anxiety and depression-like behaviors. RESULTS: It is difficult to unambiguously distinguish the effects of different populations of the 5-HT(1A) receptors with traditional genetic animal models and pharmacological approaches. However, with the advent of novel genetic systems and subpopulation-selective pharmacological agents, direct evidence for the distinct roles of these populations in governing emotion-related behavior is emerging. CONCLUSIONS: There is strong and growing evidence for a functional dissociation between auto- and heteroreceptor populations in mediating anxiety and depressive-like behaviors, respectively. Furthermore, while it is well established that 5-HT(1A) receptors act developmentally to establish normal anxiety-like behaviors, the developmental role of 5-HT(1A) heteroreceptors is less clear, and the specific mechanisms underlying the developmental role of each subpopulation are likely to be key elements determining mood control in adult subjects.
Authors: Carolyn Cidis Meltzer; Julie C Price; Chester A Mathis; Meryl A Butters; Scott K Ziolko; Eydie Moses-Kolko; Sati Mazumdar; Benoit H Mulsant; Patricia R Houck; Brian J Lopresti; Lisa A Weissfeld; Charles F Reynolds Journal: Neuropsychopharmacology Date: 2004-12 Impact factor: 7.853
Authors: S Ramboz; R Oosting; D A Amara; H F Kung; P Blier; M Mendelsohn; J J Mann; D Brunner; R Hen Journal: Proc Natl Acad Sci U S A Date: 1998-11-24 Impact factor: 11.205
Authors: Alvaro L Garcia-Garcia; Qingyuan Meng; Sarah Canetta; Alain M Gardier; Bruno P Guiard; Christoph Kellendonk; Alex Dranovsky; E David Leonardo Journal: Cell Rep Date: 2017-01-31 Impact factor: 9.423
Authors: Katherine M Nautiyal; Laurent Tritschler; Susanne E Ahmari; Denis J David; Alain M Gardier; René Hen Journal: Neuropsychopharmacology Date: 2016-06-29 Impact factor: 7.853
Authors: Valérie Turcotte-Cardin; Faranak Vahid-Ansari; Christine Luckhart; Mireille Daigle; Sean D Geddes; Kenji F Tanaka; René Hen; Jonathan James; Zul Merali; Jean-Claude Béïque; Paul R Albert Journal: J Neurosci Date: 2018-12-14 Impact factor: 6.167
Authors: Miranda L Groft; Marigny C Normann; Paige R Nicklas; Julia E Jagielo-Miller; Peter J McLaughlin Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2019-07-09 Impact factor: 3.000
Authors: Benjamin Adam Samuels; Indira Mendez-David; Charlène Faye; Sylvain André David; Kerri A Pierz; Alain M Gardier; René Hen; Denis J David Journal: Neuroscientist Date: 2014-12-08 Impact factor: 7.519
Authors: Michael Strupp-Levitsky; Jeffrey M Miller; Harry Rubin-Falcone; Francesca Zanderigo; Matthew S Milak; Gregory Sullivan; R Todd Ogden; Maria A Oquendo; Christine DeLorenzo; Norman Simpson; Ramin V Parsey; J John Mann Journal: Psychiatry Res Neuroimaging Date: 2016-08-08 Impact factor: 2.376